From complex oncology protocols to high-volume vaccine studies, Medable brings clinical expertise, patient-centered technology, and global delivery experience to eCOA, eConsent, and more.

Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here. Subcopy goes here.
Medable Study Studio helps teams streamline eCOA design and implementation with reusable components, established instrument knowledge, and more efficient study builds.
Intuitive user experiences help make reporting more manageable, supporting consistent participation and data collection.
Standardized study components and localization capabilities help sponsors manage requirements across countries, languages, and sites.
Large-scale clinical trials bring added complexity—from thousands of participants and high volumes of patient-reported data to global site coordination, device logistics, and demanding study timelines.Medable combines scalable eCOA technology, global delivery expertise, and device and logistics support to help sponsors manage large, complex trials while maintaining a consistent patient experience and reliable data collection

tbd
Tbd
Tbd

A top-5 pharma partnered with Medable on two pediatric vaccine studies in South Africa, where parents and guardians consent on behalf of their children. By reviewing consent materials from the caregiver’s perspective, Medable flagged inconsistencies early enough for the sponsor to revise the forms and secure IRB re-approval before first patient in.

Learn how Medable enabled a top-5 pharma to scale vaccine mega-trials with near-100% enrollment, real-time safety data, and >90% diary compliance.

How do you drive adoption in a complex women’s health study? See how ICON and Medable reached 85% eConsent uptake across 1,200+ participants with a smarter, site-first approach.